Fundraising FAQs
Fancy fundraising for Retina UK? Here’s a few pointers to help get you started.
Search
Search results
Positive early findings from ProQR trial of USH2A therapy
Biotechnology company ProQR has announced encouraging results from its early analysis of the phase 1/2 trial of QR-421a, an innovative approach to treating sight loss caused by mutations in a particular section of the USH2A gene.
e-Newsletter August 2023
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Tough Mudder 2025
With various events to choose from in 2025, these hugely popular events are back for another year! Round up your friends, family members and colleagues and join #TeamRetinaUK for a fun day out!
Inflatable Assault Courses 2025
With various events to choose from in 2025, these hugely popular events are back for another year! Round up your friends, family members and colleagues and join #TeamRetinaUK for a fun day out!
Bungee Jumping
With various locations to choose from in 2025, these hugely popular jumps are back for another year! Join #TeamRetinaUK for a fun day out in 2025.
Retinitis Pigmentosa Awareness Month 2025
February is Retinitis Pigmentosa Awareness Month and we'd love you to get involved to enhance the work of Retina UK, as we continue to support those who are living with retinitis pigmentosa and other inherited sight loss conditions.
ProQR announces agreement with Laboratoires Théa for inherited retinal disease programmes
Biotechnology company ProQR has announced that two of its RNA therapy development programmes for inherited sight loss are being acquired by Laboratoires Théa, a company specialising in eye care products.
Royal Parks Half Marathon 2025
The stunning 13.1-mile route takes in many of the capital’s world-famous landmarks on closed roads, and four of London’s eight Royal Parks – Hyde Park, The Green Park, St James’s Park and Kensington Gardens.